Standard analyses of cerebrospinal fluid (CSF) markers (beta-amyloid [1–42]/ [1–40] ratio, phospho-tau) are also considered predictive of Alzheimer’s disease [53]. This evidence concerns the gene MAPT and early-onset autosomal dominant Alzheimer disease.